十一大癌种非姑息性放疗期间及放疗后三十天内死亡情况的全景分析
总体围放疗期死亡率为2.46%,从乳腺癌的0.14%到中枢神经系统肿瘤的8.52%不等,且从2004年的3.13%改善至2016年的1.78%(P < .0001)。年龄、基线合并症、男性和分期是主要预测因素,而治疗机构患者量较高和更适形放疗计划技术具有中度保护作用(P < .0001)。
要点
- 非姑息性放疗期间及30天内总死亡率为2.46%,各癌种间跨度达两个数量级(0.14%至8.52%)。
- 围放疗期死亡率从2004年3.13%逐年改善至2016年1.78%(P < .0001)。
- 无私人保险与各癌种围放疗期死亡率大幅升高相关,黑人患者在乳腺癌、淋巴瘤和胃肠道癌中死亡率更高。
核心结论
- 围放疗期死亡率因患者、肿瘤和治疗等多因素而差异显著,社会人口学差异提示健康差异领域和质量改进机会。
- 早期识别高风险患者可能有助于实施更密切监测或其他预防措施。
研究设计与样本
- 基于美国国家癌症数据库的回顾性分析,纳入2004至2016年接受非姑息性外照射放疗的非转移性癌症患者,覆盖乳腺、前列腺、非前列腺泌尿生殖、骨/软组织、妇科、头颈、淋巴瘤、胃肠道、小细胞肺癌、非小细胞肺癌和中枢神经系统共11个癌种。
- 采用多变量逻辑回归控制17项协变量(包括患者、肿瘤和治疗因素)以识别围放疗期死亡的预测因素。
主要发现
- 围放疗期死亡率从2004年的3.13%稳步改善至2016年的1.78%(P < .0001)。
- 围放疗期死亡的主要预测因素包括年龄、基线合并症、男性和分期(P < .0001);治疗机构患者量较高和更适形放疗计划技术的使用具有中度保护作用(P < .0001)。
- 黑人患者在乳腺癌、淋巴瘤和胃肠道癌中围放疗期死亡率升高,但在其他癌种中未观察到该差异。
- 无私人保险与所有癌种围放疗期死亡率大幅升高相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Peri-RT mortality (death during or within 30 days of non-palliative radiotherapy) has been historically overlooked, and rates and risk factors are unclear. MATERIALS AND METHODS: Patients with non-metastatic cancer, treated with non-palliative external beam radiation (RT) 2004-2016, were identified in the National Cancer Database for 11 cancer types: breast, prostate, non-prostate genitourinary, bone/soft tissue, gynecological, head/neck, lymphoma, gastrointestinal (GI), small cell lung, non-small cell lung, and central nervous system (CNS). Multivariable logistic regression was used to identify predictors of peri-RT mortality controlled for 17 covariates, including patient, tumor, and treatment factors. RESULTS: Approximately 1.53 million patients were identified. Peri-RT mortality was 2.46% overall, spanning two orders of magnitude from 0.14% for breast to 8.52% for CNS. Peri-RT mortality steadily improved from 3.13% in 2004 to 1.78% in 2016 (P < .0001). Major predictors of peri-RT mortality included age, baseline comorbidity, male sex, and stage (P < .0001). Conversely, higher patient volume at the treating facility and use of more conformal RT planning techniques were moderately protective (P < .0001). Racial disparities varied based on disease site, as Black patients had increased peri-RT mortality for breast, lymphoma, and GI cancers, but not for other cancer types. Lack of private insurance was associated with substantially increased peri-RT mortality regardless of cancer type. CONCLUSION: Peri-RT mortality varied considerably according to multiple factors. Sociodemographic differences highlight areas of health disparities and opportunities for quality improvement. Early recognition of patients at increased risk may facilitate implementation of closer monitoring or other preventive measures.
引用
- Xiang M, Raldow AC, Pollom EL, et al. Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types. Radiother Oncol. 2022. PMID: 35033605. doi:10.1016/j.radonc.2022.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。